TherapeuticsMD Inc. buy stratec
Start price
26.10.18
/
50%
€242.64
Target price
04.11.21
€200.00
Performance (%)
-86.61%
End price
05.11.21
€32.50
Summary
This prediction ended on 05.11.21 with a price of €32.50. The BUY prediction by stratec for TherapeuticsMD Inc. performed very badly with a performance of -86.61%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
TherapeuticsMD Inc. | 0.000% | 0.000% | -45.570% | -96.220% |
iShares Core DAX® | 0.961% | -2.210% | 12.839% | 17.154% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% | 45.463% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% | 5.076% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% | 42.583% |
Comments by stratec for this prediction
In the thread Therapeuticsmd Inc. diskutieren
stratec stimmt der Buy-Einschätzung der institutionellen Analysten zu
TherapeuticsMD announces that it is discussing labeling with the FDA related to hormone therapy candidate TX-001HR.
The agency's action date for its proposed use for treating moderate-to-severe vasomotor symptoms due to menopause is October 28, but a decision may be announced today.
Kursziel geändert auf 4,0
In the thread Trading Therapeuticsmd Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten